Does Abatacept Increase Postoperative Adverse Events in Rheumatoid Arthritis Compared with Conventional Synthetic Disease-modifying Drugs?
Hiromu ItoShigeyoshi TsujiMasanori NakayamaYuichi MochidaKeiichiro NishidaHajime IshikawaToshihisa KojimaTakumi MatsumotoAyako KubotaTakeshi MochizukiKoji SakurabaIsao MatsushitaArata NakajimaRyota HaraAkihisa HaraguchiTsukasa MatsubaraKatsuaki KanbeNatsuko NakagawaMasahide HamaguchiShigeki Momoharanull nullPublished in: The Journal of rheumatology (2019)
Compared with csDMARD and/or steroids without ABA, adding ABA to the treatment does not appear to increase the incidence rates of postoperative AE in patients with RA undergoing orthopedic surgery. Large cohort studies should be performed to add evidence for the perioperative safety profile of ABA.
Keyphrases
- rheumatoid arthritis
- patients undergoing
- transcription factor
- arabidopsis thaliana
- disease activity
- minimally invasive
- ankylosing spondylitis
- interstitial lung disease
- coronary artery bypass
- risk factors
- cardiac surgery
- rheumatoid arthritis patients
- systemic lupus erythematosus
- acute coronary syndrome
- combination therapy
- idiopathic pulmonary fibrosis
- smoking cessation